NCT03024697

Brief Summary

In this proposed study, the investigators are looking to conduct a prospective, randomised, double-blind, non-inferiority trial, to study single-shot pectoral plane (PECs) blocks versus continuous local anaesthetic infusion analgesia versus a combination of PECs blocks and local anaesthetic infusion analgesia, when it comes to providing analgesia for most forms of breast surgery. Breast surgery is common, and the optimal form of analgesia is currently unknown. Techniques involving local anaesthetic, such as pectoral plane (PECs) blocks and infusion pumps, are growing in popularity, as they reduce the amount of opioid medications used. Opioids are associated with nausea, vomiting, low blood pressure, drowsiness and constipation, and as such, opioid-sparing analgesic regimens postoperatively are becoming more common. These regimens will typically involve paracetamol, a NSAID (non-steroidal anti-inflammatory drug), and a local anaesthetic technique. Pectoral plane blocks involve a once-off injection of local anaesthetic at two locations within the chest wall, typically done after the patient undergoes general anaesthesia, but before the commencement of surgery. Local anaesthetic infusion pumps involve the insertion of a catheter into the wound at the end of surgery, before the patient emerges from general anaesthesia, that constantly emit local anaesthetic over a defined period of time. Each technique is considered extremely safe, and is considered acceptable as a form of pain relief in patients undergoing breast surgery. There are no published works comparing pectoral plane blocks with local anaesthetic infusion pump analgesia, and the investigators see a gap in the knowledge base that can be addressed. This study will allow efficacy, safety and cost of the three techniques to be compared. The investigators feel the study design is robust, and statistical analysis based on previously published works in the area of postoperative analgesia has allowed the study to be powered appropriately. Patients undergoing breast surgery are a vulnerable group, and this is recognised via the provision of a comprehensive Patient Information Leaflet and a commitment to respecting the process of Informed Consent. The investigators also recognise this is a stressful period in a woman's life, and the study will be conducted in a sensitive and compassionate manner. The study has been designed to be prospective, randomised, and double-blinded. The anaesthetic will be standardised in relation to analgesic and anti-emetic agents administered, in order to minimise variables. Chronic post-surgical pain is a growing area of research, and the follow-up telephone interview at 3-months will allow investigation of this. A Data Record Form will be utilised for data collection, which will subsequently be analysed statistically. Data will be handled sensitively, securely, and by the minimum number of researchers. A plan is in place for destruction of data at an appropriate time. While there will be no direct benefit to participants, including monetary considerations, this research study will add to the knowledge-base surrounding analgesia for breast surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jan 2017

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

January 15, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 19, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

September 11, 2017

Status Verified

September 1, 2017

Enrollment Period

4 months

First QC Date

January 15, 2017

Last Update Submit

September 6, 2017

Conditions

Keywords

Breast surgeryPectoral plane blockPECsLocal anaesthesia infusionAnalgesia

Outcome Measures

Primary Outcomes (1)

  • Area under curve of verbal rating score (VRS) of pain moving versus time

    VRS pain was measured at 1 hour, 4-6 hours, 10-14 hours, and 20-24 hours postoperatively

Secondary Outcomes (3)

  • Total postoperative opioid consumption

    Over first 24 postoperative hours

  • Postoperative nausea and vomiting

    Recorded at the following time points after surgery: 1 hour, 2-4 hours, 6-8 hours, 10-14 hours 20-24 hours

  • Postoperative sedation score

    Recorded at the following time points after surgery: 1 hour, 2-4 hours, 6-8 hours, 10-14 hours 20-24 hours

Study Arms (3)

PECs Block

ACTIVE COMPARATOR

Patients randomised to receive pectoral plane blocks and a sham local anaesthetic infusion wound catheter

Procedure: Pectoral Plane Block

LA Infusion

ACTIVE COMPARATOR

Patients randomised to receive a local anaesthetic infusion wound catheter; No sham pectoral plane block performed as patients usually under general anaesthetic at time of block.

Procedure: Local Anaesthetic Wound Infusion Catheter

PECs Block & LA Infusion

ACTIVE COMPARATOR

Patients randomised to receive pectoral plane blocks and a local anaesthetic infusion wound catheter.

Procedure: Pectoral Plane BlockProcedure: Local Anaesthetic Wound Infusion Catheter

Interventions

Also known as: PECs Block
PECs BlockPECs Block & LA Infusion

Levobupivicaine 0.1% @10ml/hr via a wound infusion catheter

Also known as: Local Anaesthetic Infusion
LA InfusionPECs Block & LA Infusion

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • Undergoing breast surgery, including wide local excision (WLE) and sentinel lymph node biopsy (SLNB), mastectomy +- SLNB

You may not qualify if:

  • Male
  • Undergoing flap reconstruction breast surgery, implant surgery or bilateral breast surgery
  • Chronic pain syndrome
  • Local anaesthetic allergy
  • Contraindication to routine postoperative analgesia, e.g. paracetamol
  • Contraindication to regional anaesthesia, i.e. localised infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesia, Mater Misericordiae University Hospital

Dublin, Ireland

Location

Related Publications (1)

  • O'Scanaill P, Keane S, Wall V, Flood G, Buggy DJ. Single-shot pectoral plane (PECs I and PECs II) blocks versus continuous local anaesthetic infusion analgesia or both after non-ambulatory breast-cancer surgery: a prospective, randomised, double-blind trial. Br J Anaesth. 2018 Apr;120(4):846-853. doi: 10.1016/j.bja.2017.11.112. Epub 2018 Feb 14.

MeSH Terms

Conditions

Breast DiseasesBites and StingsAgnosia

Condition Hierarchy (Ancestors)

Skin DiseasesSkin and Connective Tissue DiseasesPoisoningChemically-Induced DisordersWounds and InjuriesPerceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Donal Buggy

    Mater Misericordiae University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Sean Keane; Anaesthesia SpR

Study Record Dates

First Submitted

January 15, 2017

First Posted

January 19, 2017

Study Start

January 1, 2017

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

September 11, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share

IPD will not be made available to other researchers as this has been pre-determined with patients as part of the process of informed consent.

Locations